Bianchi Lab retweetledi
March is Amyloidosis Awareness Month!
We applaud the Amyloidosis Foundation for their continued work to raise awareness and support the amyloidosis community.
Learn more: amyloidosis.org/light-the-nigh…
English
Bianchi Lab
412 posts
Bianchi Lab
@TheBianchiLab
Physician-Scientist running a hypothesis-driven research program to develop effective therapies for Amyloidosis and Myeloma patients. @brighamheme @harvardmed
Boston, MA Katılım Eylül 2021
206 Takip Edilen559 Takipçiler
Bianchi Lab retweetledi
I just heard this news. Chris Sims was a giant of the profession who profoundly changed empirical macro and to some extent finance. He was also my adviser, mentor, and role model. Very generous with his time. Very sad day.
Noah Williams@Bellmanequation
Essence of Chris Sims right here (start at 8:36) R.I.P. youtube.com/watch?v=bVIOCl…
English
Bianchi Lab retweetledi
Peter Arcidiacono has officially joined JHU econ and the new school of policy with a joint appointment. I don't think that I need to explain how significant this hire is!
public.econ.duke.edu/~psarcidi/
Francesco Bianchi@Francesco_Bia
100% correct! And with strong ties with the rest of the @JohnsHopkins community, including the econ department. We are looking at multiple joint appointments over the years, with one already in place and more to come soon!
English
Bianchi Lab retweetledi
I am very happy to announce that Thomas Drechsel @td_econ will be joining @JohnsHopkins econ! A fantastic hire that further strengthens our department. Thomas has a very broad research agenda, spanning Monetary Economics, International Macro, HANK,... Welcome to JHU Thomas!
English
Bianchi Lab retweetledi
Congratulations to Alice Shaw, MD, PhD, Kimberly Stegmaier, MD, and Matthew Vander Heiden, MD, PhD, on being elected as Fellows of the @AACR Academy Class of 2026. Learn more: bit.ly/45KykqC
English
Congrats @vhugo8762 ! Good luck on this new adventure.
Victor H Jimenez-Zepeda@vhugo8762
Very excited to start this new position @WCMMyelomaCtr and contribute to the treatment of MM and AL amyloidosis. To my Canadian peeps, it was a great journey and will always be grateful to @NBahlis and all my Canadian myeloma docs for the support! @MyelomaCanada
English
Bianchi Lab retweetledi
Why is a conflict between fiscal and monetary policy dangerous? @LeonardoMelosi and I show that when fiscal authorities ignore debt sustainability while central banks fight inflation, the economy can enter a vicious spiral of high inflation, recessions, and more debt accumulation
English
Fantastic work @MatthewHoMD and all. Congrats!!
Matthew Ho@MatthewHoMD
@RahulBanerjeeMD @NatureMedicine Thanks for sharing Dr Banerjee! Re point 2: we did not necessarily observe CD4-specific activity in maraviroc. Maraviroc inhibited BCMA-CART proliferation in vitro (both CD4 and CD8 subsets) without affecting cytotoxicity. @paruzzol is working on validating this in vivo!
English
Bianchi Lab retweetledi
@RahulBanerjeeMD @NatureMedicine Thanks for sharing Dr Banerjee!
Re point 2: we did not necessarily observe CD4-specific activity in maraviroc. Maraviroc inhibited BCMA-CART proliferation in vitro (both CD4 and CD8 subsets) without affecting cytotoxicity.
@paruzzol is working on validating this in vivo!
English
Excited to chat with @SLentzsch and @Amyloid_Planet about all things AL amyloidosis. Hope to see many joining the discussion! @DanaFarber @BWHAmyloid
English
Bianchi Lab retweetledi
Congratulations to Robert Soiffer, MD, the 2025 recipient of the Edward J. Benz Award for Advancing the Careers of Dana-Farber Faculty. This annual award recognizes a faculty member who goes above and beyond to advance the careers of fellow faculty. We thank Dr. Soiffer for his continued dedication and leadership, which truly exemplify this honor.
English
Bianchi Lab retweetledi
Stop by our trial in progress poster on Tec-Dara fixed duration (6 cycles) in newly diagnosed AL amyloidosis @SLentzsch @vsanchorawala @SU2C @JNJInnovation #ASH25
@columbiacancer
English
Thanks for the shout out @rajshekharucms . Excited to offer this life changing treatment to AL #amyloidosis patients. Looking forward to catching up at #ASH25
Raj Chakraborty@rajshekharucms
First prospective data on elranatamab in AL #Amyloidosis by @TheBianchiLab! Love the short treatment duration of 6 months (will likely be enough in AL to achieve deep/durable hematologic responses while mitigating infection risk). n=6, with 100% VGPR or better 100% with dFLC<1 mg/dL and iFLC<2 mg/dL by C2D1 #ASH25
English
Bianchi Lab retweetledi
@mtkonczal Most papers that I know might stop a bit earlier. However, my work with @renato_faccini @LeonardoMelosi predicts a long tail of above target inflation after the pandemic spur (free access on my webpage)
academic.oup.com/qje/article-ab…
English
Bianchi Lab retweetledi
Last Friday, new NCI Director Dr. Anthony Letai met with staff for the first time.
His message:
• Fund gold-standard cancer research.
• Inspire the next generation of scientists.
• Tell our story so the public knows what their research investment makes possible.
A hopeful start, and the first of many community conversations ahead. #MAHA
English
Bianchi Lab retweetledi
I have an important update about this: we are looking to fill out 5 senior slots and 3 junior slots. Please, apply and reach out if interested! Or help me to spread out the news!
@HannoLustig @luigi_bocola @JonSteinsson @IvanWerning @glviolante @JesusFerna7026 @LudvigsonSydney x.com/Francesco_Bia/…
English
Bianchi Lab retweetledi
Bianchi Lab retweetledi
Real-world bispecific T-cell engager therapy in systemic AL amyloidosis #mmsm @AjHematology
➡️n=29 (Tec 19 | Elra 6 | Tal 4)
➡️ORR 76% → CR 66%, VGPR 7%, PR 3%
➡️Median time to ≥VGPR: 29 days
➡️Cardiac response 64% | Renal 100%
➡️1-yr OS: 77%
➡️CRS 45% (no ≥Gr3), ICANS 14%, infections ≥Gr3 in 6 pts
onlinelibrary.wiley.com/doi/10.1002/aj…
@ldandersonjr
English
Bianchi Lab retweetledi
Gentle reminder that @JohnsHopkins econ is hiring. Open field, open rank. Details below
English
Bianchi Lab retweetledi
The stock market participants are neither perfectly rational nor perfectly efficient. Yet to what degree? Toward a practical baseline of objective expectation formation, from @Francesco_Bia, Do Q. Lee, @LudvigsonSydney, and Sai Ma nber.org/papers/w34420
English